PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New agent may enhance effectiveness of radiotherapy

Scientists from The University of Manchester -- part of the Manchester Cancer Research Centre - have demonstrated the potential of a drug to improve the effectiveness of radiotherapy in stopping tumor growth

2014-05-13
(Press-News.org) Scientists from The University of Manchester – part of the Manchester Cancer Research Centre - have demonstrated the potential of a drug to improve the effectiveness of radiotherapy in stopping tumour growth.

There is increasing interest in using the body's own immune system to attack tumour cells – a strategy that can be very effective without the side effects associated with conventional chemotherapy.

Skin cancers have been successfully treated using a topical cream, imiquimod, which recruits immune cells through a molecule known as toll-like receptor 7 (TLR7), a protein that recognises foreign and potentially harmful material.

Previously, researchers in Manchester have shown that they can also stimulate the immune system into generating an immune response against non-skin cancers by injecting an agent similar to TLR7 into the blood.

In collaboration with AstraZeneca and Dainippon Sumitomo Pharma, the Manchester group have looked at another molecule that activates TLR7, known as DSR-6434. Using mouse models of two different types of cancer, they investigated DSR-6434 on its own and in combination with radiotherapy and measured the effect on the primary tumour and the number of secondary tumours in the lungs.

Professor Ian Stratford, from Manchester Pharmacy School who, with Professor Tim Illidge, led the research published in the International Journal of Cancer, said: "We have already seen a strong immune system response from other immunotherapy agents in combination with radiation – this new agent appears to be even more potent."

His team showed that administering DSR-6434 together with radiotherapy led to tumour shrinkage and increased long-term survival. They found that the combination treatment also reduced the occurrence of secondary lung tumours.

"It looks like there's good reason to use radiotherapy alongside immunotherapy agents in the treatment of solid tumours. These results strongly suggest that this sort of combination therapy should be evaluated in clinical trials with cancer patients," added Professor Stratford.

INFORMATION:


ELSE PRESS RELEASES FROM THIS DATE:

Arthroscopy of the knee joint for arthrosis: No benefit detectable

2014-05-13
The benefit of therapeutic arthroscopy with lavage and possible debridement for the treatment of arthrosis of the knee joint (gonarthrosis) is not proven. There was no hint, indication or proof of benefit of therapeutic arthroscopy in comparison with non-active comparator interventions, e.g. sham surgery, for any patient-relevant outcome. From the active comparator therapies, only the injection of glucocorticoids into the knee joint produced worse results than arthroscopy for the outcome "global assessment of the symptoms of gonarthrosis". This was the result of the ...

Identified 2 new genes involved in the more aggressive prostate cancer

Identified 2 new genes involved in the more aggressive prostate cancer
2014-05-13
A study by the Columbia University Nova York, in collaboration with the Catalan Institute of Oncology , Belvitge Biomedical Research Institute (ICO-IDIBELL) has identified two new genes that lead to more aggressive forms of prostate cancer. The work done by Alvaro Aytes under the direction of Cory Abate-Shen , director of the Herbert Irving Comprehensive Cancer Center of the Columbia University, has been published in the latest issue of Cancer Cell. Prostate cancer Prostate cancer is the most common in men in Europe( accounts for 20% of all male tumors). The incidence ...

A tale of survival

2014-05-13
Frankfurt am Main, Germany, May 12, 2014. Hydrogen sulphide (H2S) is a potent inhibitor of aerobic respiration. However populations of shortfin molly fish managed to colonise springs with high concentrations of dissolved hydrogen sulphide. In a new study researchers from LOEWE Biodiversity and Climate Research Centre (BiK-F) and the Goethe University Frankfurt present evidence of genetic changes minimizing the harmful effects of H2S which enable the fish to survive in this deleterious environment. The study provides insight into the molecular mechanisms of this key adaptation ...

Bird invaders 'moving in' to UK's nature reserves

2014-05-13
A new study by scientists at the University of York and the RSPB Centre for Conservation Science has demonstrated that nature reserves and other areas specially protected for wildlife, as well as being vital for native species, are very important for helping European birds to expand their ranges into Britain naturally. The catch is that protected areas are also at increasing risk of invasion by species that have been introduced from further afield. The research, published in the journal Diversity and Distributions, explores how the UK's special places for nature have ...

Comet theory false; doesn't explain Ice Age cold snap, Clovis changes, animal extinction

2014-05-13
Controversy over what sparked the Younger Dryas, a brief return to near glacial conditions at the end of the Ice Age, includes a theory that it was caused by a comet hitting the Earth. As proof, proponents point to sediments containing deposits they believe could result only from a cosmic impact. Now a new study disproves that theory, said archaeologist David Meltzer, Southern Methodist University, Dallas. Meltzer is lead author on the study and an expert in the Clovis culture, the peoples who lived in North America at the end of the Ice Age. Meltzer's research team ...

Chemists design molecules for controlling bacterial behavior

Chemists design molecules for controlling bacterial behavior
2014-05-13
Chemists in the College of Arts and Sciences have figured out how to control multiple bacterial behaviors—potentially good news for the treatment of infectious diseases and other bacteria-associated issues, without causing drug resistance. Yan-Yeung Luk, associate professor of chemistry, has spearheaded the discovery, in conjunction with his research lab at Syracuse University and the Wang Lab at SUNY Upstate Medical University. Their findings are the subject of a forthcoming article in the journal ChemBioChem (John Wiley & Sons Inc.). "Since the discovery of the first ...

UCSF: E-cigarettes expose people to more than harmless vapor, should be regulated

2014-05-13
In a major scientific review of research on e-cigarettes, UC San Francisco scientists found that industry claims about the devices are unsupported by the evidence to date, including claims that e-cigarettes help smokers quit. The review marks the first comprehensive assessment of peer-reviewed published research into the relatively new phenomenon of electronic cigarettes. The devices, which are rapidly gaining a foothold in popular culture particularly among youth, are marketed as a healthier alternative to tobacco smoking, as an effective tool to stop smoking, ...

Scientists from USC and NYU design a molecule that blocks cancer growth in mice

2014-05-13
A team of researchers from USC and NYU has developed and patented a small molecule that interferes with cancer progression with minimal side effects. The molecule prevents two critical proteins from interacting by mimicking the surface topography of one protein – like wearing a mask – which tricks the other protein into binding with it. This stops a so-called "transcription factor" that controls the transcription of genetic information. That transcription factor is what would have created an aberrant gene expression, contributing to the cancer growth. Because of the ...

Scientists slow brain tumor growth in mice

Scientists slow brain tumor growth in mice
2014-05-13
Much like using dimmer switches to brighten or darken rooms, biochemists have identified a protein that can be used to slow down or speed up the growth of brain tumors in mice. Brain and other nervous system cancers are expected to claim 14,320 lives in the United States this year. The results of the preclinical study led by Eric J. Wagner, Ph.D., and Ann-Bin Shyu, Ph.D., of The University of Texas Health Science Center at Houston (UTHealth) and Wei Li, Ph.D., of Baylor College of Medicine appear in the Advance Online Publication of the journal Nature. "Our work ...

Birth by C-section, early antibiotic use put kids at risk for allergic esophagitis

2014-05-13
Children delivered by cesarean section and those given antibiotics during early infancy appear more prone to developing allergic inflammation of the esophagus — the muscular tube that connects the mouth to the stomach — according to results of a study by investigators from the Johns Hopkins Children's Center and Harvard Medical School. The findings, published online May 2 in the Journal of Allergy and Clinical Immunology: In Practice, reveal that early antibiotic treatment and C-section delivery may somehow precipitate disease development by altering a child's microbiota ...

LAST 30 PRESS RELEASES:

We should talk more at school: Researchers call for more conversation-rich learning as AI spreads

LHAASO uncovers mystery of cosmic ray "knee" formation

The simulated Milky Way: 100 billion stars using 7 million CPU cores

Brain waves’ analog organization of cortex enables cognition and consciousness, MIT professor proposes at SfN

Low-glutamate diet linked to brain changes and migraine relief in veterans with Gulf War Illness

AMP 2025 press materials available

New genetic test targets elusive cause of rare movement disorder

A fast and high-precision satellite-ground synchronization technology in satellite beam hopping communication

What can polymers teach us about curing Alzheimer's disease?

Lead-free alternative discovered for essential electronics component

BioCompNet: a deep learning workflow enabling automated body composition analysis toward precision management of cardiometabolic disorders

Skin cancer cluster found in 15 Pennsylvania counties with or near farmland

For platforms using gig workers, bonuses can be a double-edged sword

Chang'e-6 samples reveal first evidence of impact-formed hematite and maghemite on the Moon

New study reveals key role of inflammasome in male-biased periodontitis

MD Anderson publicly launches $2.5 billion philanthropic campaign, Only Possible Here, The Campaign to End Cancer

Donors enable record pool of TPDA Awards to Neuroscience 2025

Society for Neuroscience announces Gold Sponsors of Neuroscience 2025

The world’s oldest RNA extracted from woolly mammoth

Research alert: When life imitates art: Google searches for anxiety drug spike during run of The White Lotus TV show

Reading a quantum clock costs more energy than running it, study finds

Early MMR vaccine adoption during the 2025 Texas measles outbreak

Traces of bacteria inside brain tumors may affect tumor behavior

Hypertension affects the brain much earlier than expected

Nonlinear association between systemic immune-inflammation index and in-hospital mortality in critically ill patients with chronic obstructive pulmonary disease and atrial fibrillation: a cross-sectio

Drift logs destroying intertidal ecosystems

New test could speed detection of three serious regional fungal infections

New research on AI as a diagnostic tool to be featured at AMP 2025

New test could allow for more accurate Lyme disease diagnosis

New genetic tool reveals chromosome changes linked to pregnancy loss

[Press-News.org] New agent may enhance effectiveness of radiotherapy
Scientists from The University of Manchester -- part of the Manchester Cancer Research Centre - have demonstrated the potential of a drug to improve the effectiveness of radiotherapy in stopping tumor growth